نتایج جستجو برای: rotavirus vaccine

تعداد نتایج: 115323  

Journal: :The Journal of infectious diseases 1996
M K Estes

The first candidate rotavirus vaccine was a live attenuated oral vaccine made by the classical empirical method of serial passage of virus in tissue culture cells. Current tetravalent vaccine candidates that are in the final stages of efficacy testing in the United States were made by genetic reassortment. This article briefly highlights how advances in the basic understanding of the molecular ...

2017
Darwin J Operario James A Platts-Mills Sandrama Nadan Nicola Page Mapaseka Seheri Jeffrey Mphahlele Ira Praharaj Gagandeep Kang Irene T Araujo Jose Paulo G Leite Daniel Cowley Sarah Thomas Carl D Kirkwood Francis Dennis George Armah Jason M Mwenda Pushpa Ranjan Wijesinghe Gloria Rey Varja Grabovac Chipo Berejena Chibumbya J Simwaka Jeannine Uwimana Jeevan B Sherchand Hlaing Myat Thu Geethani Galagoda Isidore J O Bonkoungou Sheriffo Jagne Enyonam Tsolenyanu Amadou Diop Christabel Enweronu-Laryea Sam-Aliyah Borbor Jie Liu Timothy McMurry Benjamin Lopman Umesh Parashar John Gentsch A Duncan Steele Adam Cohen Fatima Serhan Eric R Houpt

Background The etiology of acute watery diarrhea remains poorly characterized, particularly after rotavirus vaccine introduction. Methods We performed quantitative polymerase chain reaction for multiple enteropathogens on 878 acute watery diarrheal stools sampled from 14643 episodes captured by surveillance of children <5 years of age during 2013-2014 from 16 countries. We used previously dev...

2018
Daniel Hungerford Roberto Vivancos Jonathan M Read Miren Iturriza-Gόmara Neil French Nigel A Cunliffe

BACKGROUND Rotavirus causes severe gastroenteritis in infants and young children worldwide. The UK introduced the monovalent rotavirus vaccine (Rotarix®) in July 2013. Vaccination is free of charge to parents, with two doses delivered at 8 and 12 weeks of age. We evaluated vaccine impact across a health system in relation to socioeconomic deprivation. METHODS We used interrupted time-series a...

Journal: :MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 1999
Brian W. J. Mahy John F. Modlin

These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of an oral, live rotavirus vaccine licensed by the Food and Drug Administration on August 31, 1998, for use among infants. This report reviews the epidemiology of rotavirus, describes the licensed rotavirus vaccine, and makes recommendations regarding its use for the routine...

2015
Masahiro Hashizume Toyoko Nakagomi Osamu Nakagomi

Rotavirus is a leading cause of severe acute gastroenteritis in children worldwide, and globally licensed vaccines are available. To expedite the introduction of rotavirus vaccines in the national immunisation programme, a simple, ecological method to monitor changes in the burden of rotavirus disease may be of great help. Here, we report an application of a time-series analysis on a publicly-a...

2018
Khuzwayo C Jere Chrispin Chaguza Naor Bar-Zeev Jenna Lowe Chikondi Peno Benjamin Kumwenda Osamu Nakagomi Jacqueline E Tate Umesh D Parashar Robert S Heyderman Neil French Nigel A Cunliffe Miren Iturriza-Gomara

To combat the high burden of rotavirus gastroenteritis, multiple African countries have introduced rotavirus vaccines into their childhood immunization programs. Malawi incorporated a G1P[8] rotavirus vaccine (Rotarix) into its immunization schedule in 2012. Utilizing a surveillance platform of hospitalized rotavirus gastroenteritis cases, we examined the phylodynamics of G1P[8] rotavirus strai...

2014
S A Madhi

228 March 2014, Vol. 104, No. 3 (Suppl 1) Rationale for pneumococcal conjugate vaccine and rotavirus vaccine introduction into public immunisation programmes While progress has been made in preventing deaths due to some of the vaccine-preventable diseases (e.g. measles deaths reduced from 535 000 in 2000 to 139 000 by 2010), a greater proportion of vaccine-preventable deaths is now attributed t...

2017
E. Anthony S. Nelson A. Duncan Steele

By December 2016, 81 of the 194 World Health Organization (WHO) member states (42%) had introduced rotavirus vaccine into their National Immunization Program (NIP); and several others had introduced it at the subnational level. The promising early introduction of rotavirus vaccines in 8 countries in 2006, when the vaccines were first licensed in Europe (Rotarix, GSK, Belgium) and the United Sta...

Journal: :Therapeutics and Clinical Risk Management 2008
Richard L Ward Monica M McNeal A Duncan Steele

A "Meeting on Upstream Rotavirus Vaccines and Emerging Vaccine Producers" was held at the World Health Organization in Geneva, Switzerland on March 28-30, 2006. The purpose was to discuss, evaluate, and weigh the importance of additional rotavirus vaccine candidates following the successful international licensure of rotavirus vaccines by two major pharmaceutical companies (GlaxoSmithKline and ...

Journal: :Memorias do Instituto Oswaldo Cruz 2002
J D P Mascarenhas A C Linhares Y B Gabbay J P G Leite

This study sought the characterization of rotaviruses in a trial with a tetravalent rhesus-human rotavirus vaccine in Belém, Brazil in children who received three doses of vaccine or placebo in the 1st, 3rd and 5th months of life. Rotavirus electropherotypes, subgroups, G serotypes, G, [P] and [P], G genotypes were determined in 93.3%, 95.9%, 93.3%, 73.3%, 95.5% and 92.2% of isolates, respectiv...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید